165 related articles for article (PubMed ID: 37874983)
1. Reduced Insulin Clearance Differently Relates to Increased Liver Lipid Content and Worse Glycemic Control in Recent-Onset Type 2 and Type 1 Diabetes.
Zaharia OP; Antoniou S; Bobrov P; Karusheva Y; Bódis K; Kupriyanova Y; Schrauwen-Hinderling V; Gastaldelli A; Szendroedi J; Wagner R; Burkart V; Roden M;
Diabetes Care; 2023 Dec; 46(12):2232-2239. PubMed ID: 37874983
[TBL] [Abstract][Full Text] [Related]
2. Correlates of Insulin-Stimulated Glucose Disposal in Recent-Onset Type 1 and Type 2 Diabetes.
Simon MC; Möller-Horigome A; Strassburger K; Nowotny B; Knebel B; Müssig K; Herder C; Szendroedi J; Roden MW;
J Clin Endocrinol Metab; 2019 Jun; 104(6):2295-2304. PubMed ID: 30689904
[TBL] [Abstract][Full Text] [Related]
3. Reduced Muscle Strength Is Associated With Insulin Resistance in Type 2 Diabetes Patients With Osteoarthritis.
Zaharia OP; Pesta DH; Bobrov P; Kupriyanova Y; Herder C; Karusheva Y; Bódis K; Bönhof GJ; Knitza J; Simon D; Kleyer A; Hwang JH; Müssig K; Ziegler D; Burkart V; Schett G; Roden M; Szendroedi J
J Clin Endocrinol Metab; 2021 Mar; 106(4):1062-1073. PubMed ID: 33382877
[TBL] [Abstract][Full Text] [Related]
4. Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus.
Kupriyanova Y; Zaharia OP; Bobrov P; Karusheva Y; Burkart V; Szendroedi J; Hwang JH; Roden M;
J Hepatol; 2021 May; 74(5):1028-1037. PubMed ID: 33259845
[TBL] [Abstract][Full Text] [Related]
5. Specific Metabolic Profiles and Their Relationship to Insulin Resistance in Recent-Onset Type 1 and Type 2 Diabetes.
Knebel B; Strassburger K; Szendroedi J; Kotzka J; Scheer M; Nowotny B; Müssig K; Lehr S; Pacini G; Finner H; Klüppelholz B; Giani G; Al-Hasani H; Roden M;
J Clin Endocrinol Metab; 2016 May; 101(5):2130-40. PubMed ID: 26829444
[TBL] [Abstract][Full Text] [Related]
6. Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes.
Zaharia OP; Strassburger K; Knebel B; Kupriyanova Y; Karusheva Y; Wolkersdorfer M; Bódis K; Markgraf DF; Burkart V; Hwang JH; Kotzka J; Al-Hasani H; Szendroedi J; Roden M;
Diabetes Care; 2020 Sep; 43(9):2161-2168. PubMed ID: 32910776
[TBL] [Abstract][Full Text] [Related]
7. Expansion and Impaired Mitochondrial Efficiency of Deep Subcutaneous Adipose Tissue in Recent-Onset Type 2 Diabetes.
Bódis K; Jelenik T; Lundbom J; Markgraf DF; Strom A; Zaharia OP; Karusheva Y; Burkart V; Müssig K; Kupriyanova Y; Ouni M; Wolkersdorfer M; Hwang JH; Ziegler D; Schürmann A; Roden M; Szendroedi J;
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1331-43. PubMed ID: 31838512
[TBL] [Abstract][Full Text] [Related]
8. Association of thyroid function with non-alcoholic fatty liver disease in recent-onset diabetes.
Saatmann N; Schön M; Zaharia OP; Huttasch M; Strassburger K; Trenkamp S; Kupriyanova Y; Schrauwen-Hinderling V; Kahl S; Burkart V; Wagner R; Roden M;
Liver Int; 2024 Jan; 44(1):27-38. PubMed ID: 37697960
[TBL] [Abstract][Full Text] [Related]
9. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
[TBL] [Abstract][Full Text] [Related]
10. Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes.
Schön M; Zaharia OP; Strassburger K; Kupriyanova Y; Bódis K; Heilmann G; Strom A; Bönhof GJ; Michelotti F; Yurchenko I; Möser C; Huttasch M; Bombrich M; Kelm M; Burkart V; Schrauwen-Hinderling VB; Wagner R; Roden M;
Diabetes; 2023 Oct; 72(10):1483-1492. PubMed ID: 37478166
[TBL] [Abstract][Full Text] [Related]
11. Meal-derived glucagon responses are related to lower hepatic phosphate concentrations in obesity and type 2 diabetes.
Weber KS; Straßburger K; Fritsch M; Bierwagen A; Koliaki C; Phielix E; Pacini G; Hwang JH; Markgraf DF; Burkart V; Müssig K; Szendroedi J; Roden M
Diabetes Metab; 2018 Nov; 44(5):444-448. PubMed ID: 29910091
[TBL] [Abstract][Full Text] [Related]
12. The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes.
Chan CL; Pyle L; Morehead R; Baumgartner A; Cree-Green M; Nadeau KJ
Pediatr Diabetes; 2017 Sep; 18(6):470-477. PubMed ID: 27503277
[TBL] [Abstract][Full Text] [Related]
13. Habitual Fructose Intake Relates to Insulin Sensitivity and Fatty Liver Index in Recent-Onset Type 2 Diabetes Patients and Individuals without Diabetes.
Weber KS; Simon MC; Strassburger K; Markgraf DF; Buyken AE; Szendroedi J; Müssig K; Roden M;
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29914103
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle phosphodiester content relates to body mass and glycemic control.
Szendroedi J; Schmid AI; Chmelik M; Krssak M; Nowotny P; Prikoszovich T; Kautzky-Willer A; Wolzt M; Waldhäusl W; Roden M
PLoS One; 2011; 6(7):e21846. PubMed ID: 21779337
[TBL] [Abstract][Full Text] [Related]
15. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.
Schmid AI; Szendroedi J; Chmelik M; Krssák M; Moser E; Roden M
Diabetes Care; 2011 Feb; 34(2):448-53. PubMed ID: 21216854
[TBL] [Abstract][Full Text] [Related]
16. Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage.
Lucidi P; Perriello G; Porcellati F; Pampanelli S; De Fano M; Tura A; Bolli GB; Fanelli CG
Diabetes; 2023 Oct; 72(10):1364-1373. PubMed ID: 37440717
[TBL] [Abstract][Full Text] [Related]
17. Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes.
Brouwers B; Schrauwen-Hinderling VB; Jelenik T; Gemmink A; Havekes B; Bruls Y; Dahlmans D; Roden M; Hesselink MKC; Schrauwen P
Clin Sci (Lond); 2017 Aug; 131(15):1905-1917. PubMed ID: 28620012
[TBL] [Abstract][Full Text] [Related]
18. The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus.
Nwosu BU; Maranda L
PLoS One; 2014; 9(6):e99646. PubMed ID: 24918447
[TBL] [Abstract][Full Text] [Related]
19. Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes.
Gancheva S; Bierwagen A; Kaul K; Herder C; Nowotny P; Kahl S; Giani G; Klueppelholz B; Knebel B; Begovatz P; Strassburger K; Al-Hasani H; Lundbom J; Szendroedi J; Roden M;
Diabetes; 2016 Jul; 65(7):1849-57. PubMed ID: 27207512
[TBL] [Abstract][Full Text] [Related]
20. Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity.
van Baar MJB; van Bommel EJM; Smits MM; Touw DJ; Nieuwdorp M; Ten Kate RW; Joles JA; van Raalte DH
J Diabetes Complications; 2022 Apr; 36(4):108166. PubMed ID: 35221224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
